Placebo oral liquid

DRUG2 trials

Sponsors

McGill University Health Centre/Research Institute of the McGill University Health Centre, Anavex Life Sciences Corp.

Conditions

CopdRett Syndrome

Phase 2

Effect of Sublingual Fentanyl on Breathlessness in COPD

TerminatedNCT04004117

McGill University Health Centre/Research Institute of the McGill University Health CentreCopd

Start: 2019-07-01End: 2026-02-04Updated: 2026-03-05

ANAVEX2-73 Study in Pediatric Patients With Rett Syndrome

CompletedNCT04304482

Anavex Life Sciences Corp.Rett Syndrome

Start: 2020-07-01End: 2023-06-30Updated: 2023-08-21